English
Select your language
Official EU languages:
Access to European Union law
EUR-Lex
Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
Document 62020TA0635
Case T-635/20
T-635/20
General Court
Status: Closed
T-635/20
General Court
Status: Closed
/
DECISION
- Title
- Judgment of the General Court (Third Chamber) of 6 October 2021. Dermavita Company SARL v European Union Intellectual Property Office. EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM VYBRANCE – Late payment of the appeal fee – Inadmissibility of the appeal before the Board of Appeal – Article 101(4) of Regulation (EU) 2017/1001 – Article 106(1)(b) of Regulation 2017/1001 – Restitutio in integrum. Case T-635/20.
- ECLI identifier
- ECLI:EU:T:2021:656
- Applicant
- Individual
- Defendant
- European Commission, EU institutions and bodies
- Judge-Rapporteur
- Csehi
- Type of procedure
- Action for annulment - unfounded
- Complementary documents:
29/11/2021
- Title
- Judgment of the General Court (Third Chamber) of 6 October 2021. Dermavita Company SARL v European Union Intellectual Property Office. EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM VYBRANCE – Late payment of the appeal fee – Inadmissibility of the appeal before the Board of Appeal – Article 101(4) of Regulation (EU) 2017/1001 – Article 106(1)(b) of Regulation 2017/1001 – Restitutio in integrum. Case T-635/20.
- ECLI identifier
- ECLI:EU:T:2021:656
- Applicant
- Individual
- Defendant
- European Commission, EU institutions and bodies
- Judge-Rapporteur
- Csehi
- Type of procedure
- Action for annulment - unfounded
06/10/2021
CASE BROUGHT
- Title
- Case T-635/20: Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VYBRANCE)
21/12/2020